Tracon Pharmaceuticals, Inc. Annual Return On Equity in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Tracon Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2023.
  • Tracon Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was -238 %, a 177% decline year-over-year.
  • Tracon Pharmaceuticals, Inc. annual Return On Equity for 2023 was 46.7 %, a 98.2% decline from 2022.
  • Tracon Pharmaceuticals, Inc. annual Return On Equity for 2022 was 2.62K %.
  • Tracon Pharmaceuticals, Inc. annual Return On Equity for 2021 was -182 %, a 26% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 46.7 -2.57K -98.2% Jan 1, 2023 Dec 31, 2023
2022 2.62K +2.8K Jan 1, 2022 Dec 31, 2022
2021 -182 -37.7 -26% Jan 1, 2021 Dec 31, 2021
2020 -145 +153 +51.4% Jan 1, 2020 Dec 31, 2020
2019 -298 -190 -176% Jan 1, 2019 Dec 31, 2019
2018 -108 -11.4 -11.8% Jan 1, 2018 Dec 31, 2018
2017 -96.6 +24.1 +19.9% Jan 1, 2017 Dec 31, 2017
2016 -121 -62.5 -108% Jan 1, 2016 Dec 31, 2016
2015 -58.1 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.